“…Only one study reported alterations in global development, specifically lower scores in the Denver Developmental Screening Test when comparing it with children with normal bilirubin levels(Agrawal et al, 1998).Finally, this review observed a large number of studies including a neurological evaluation. Specifically, nine studies assessed neurological function, with the most frequently used tool being the general neurological evaluation(Bengtsson & Verneholt, 1974;Besli et al, 2020;Özmert et al, 1996;Rubin et al, 1979;Wong et al, 2006), followed by the APGAR score(Gupta et al, 1990;Hokkanen et al, 2014;Lunsing et al, 2013;Rubin et al, 1979) and Prechtl's General movement assessment(Lunsing et al, 2013;Soorani-Lunsing et al, 2001), although other tests were also employed, including the Touwen's infant neurological examination(Grimmer et al, 1999), Hempel's neurologic examination(Lunsing et al, 2013), screening method of Amiel-Tison(Soorani-Lunsing et al, 2001) and Michelsson's Neurodevelopmental screening examinations(Hokkanen et al, 2014). Of note, four studies assessed the neurological risk in newborns via general movements evaluation(Kahraman et al, 2021;Lunsing et al, 2013;Soorani-Lunsing et al, 2001) or clinical risk index of babies for determining the mortality risk.…”